← Back to Search

CBIT Therapist Training for Tourette Syndrome (CBIT-Trainer Trial)

N/A

Recruiting

Led By Doug Woods, PhD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Professionally licensed or certified to practice in their area of speciality

Is willing, able, and has the necessary resources to travel to, and attend, one of several in-person training sites if assigned to the in-person training condition

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 2 weeks prior to starting treatment (baseline), 10-12 weeks from the start of treatment (post-treatment), 24-26 weeks from the start of treatment (6-month follow-up)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test an online training program to train therapists to help reduce tic symptoms in children and adults.

Who is the study for?

This trial is for licensed therapists with a Master's degree or higher in mental/behavioral health, medical, or related fields. They must be able to travel for training and find at least one patient with tic disorders to participate. Patients should have a diagnosed tic disorder, be 7 years old or older, speak English fluently, and have internet access.

What is being tested?

The study compares traditional in-person CBIT therapist training to an online self-paced program called CBIT-Trainer. It evaluates the effectiveness of each method by assessing therapists' ability to administer CBIT and the resulting change in patients' tic severity.

What are the potential side effects?

Since this trial involves educational training programs rather than medications, there are no direct side effects like those associated with drugs. However, participants may experience typical discomforts related to learning new therapeutic techniques.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am licensed or certified in my professional field.

Select...

I can travel and attend in-person training if needed.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 2 weeks prior to starting treatment (baseline), 10-12 weeks from the start of treatment (post-treatment), 24-26 weeks from the start of treatment (6-month follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 2 weeks prior to starting treatment (baseline), 10-12 weeks from the start of treatment (post-treatment), 24-26 weeks from the start of treatment (6-month follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 weeks prior to starting treatment (baseline), 10-12 weeks from the start of treatment (post-treatment), 24-26 weeks from the start of treatment (6-month follow-up) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Patient changes in overall symptom severity on the Clinical Global Impression Severity Scale (CGI-S)

Proportion of treatment responders at follow-up on the Clinical Global Impression Improvement Scale (CGI-I)

Proportion of treatment responders at post-treatment on the Clinical Global Impression Improvement Scale (CGI-I)

+3 more

Secondary study objectives

Changes in psychological/behavioral symptoms and adaptive functioning as indicated by change scores on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Profile (for adult patients only)

Patient changes in tic severity as measured by the Yale Global Tic Severity Scale (YGTSS) Total Tic Score

+5 more

Other study objectives

Number of patients reporting adverse events

Therapist change scores on the Evidence-Based Practice and Attitudes Scale (EBPAS)

Therapist scores on the Acceptability of Intervention Measure (AIM) at follow-up

+8 more